Trajan builds microscopy portfolio

Trajan builds microscopy portfolio

March 07, 2016

With a strong background in specialty glass and coatings Trajan Scientific and Medical (Trajan) has introduced a new range of microscopy products.

Trajan's General Manager, Microscopy Products, Ms Angela Tomisich says that microscopy is a key technique where premium products can be brought to market to have a positive impact on patient outcomes, in line with the Trajan vision.

“By working closely with partners in pathology and healthcare, we want to continue to develop our range of products in ways that have a positive impact on the diagnostic process. In a world that is increasingly driven to drive down healthcare costs, we want to play a strong role in ensuring that patient outcomes are not compromised.” said Ms Tomisich.

Ms Tomisich is a Director on the Board of Trajan and brings a breadth of management and clinical research experience. She attained a Bachelor of Applied Science (Applied Chemistry) from RMIT, Melbourne, Australia, and Bachelor of Science (Biomedical Science) from Deakin University, Melbourne, Australia. In 2006, she was also placed on the Cornell University Dean’s List following a cell physiology and genomics program in Ithaca, USA.

Prior to Trajan, Ms Tomisich was involved the monitoring of clinical trials in Australia and New Zealand for protocols that were complex and required knowledge in advanced therapeutic areas, including oncology, cardiology, and neurology.

Ms Tomisich is also a member of the Digital Pathology Association, and has a keen interest in emerging methods and technologies to improve diagnostic practices.

For a preview of Trajan’s capabilities in microscopy products, please view the page below or contact the Trajan team directly to discuss your microscopy requirements.


Angela Tomisich, General Manager, Microscopy Products

More information
Microscopy Products




Also in News

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More

Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare
Trajan acquires personalised blood testing business to strengthen move into data-based preventative healthcare

April 16, 2021

Trajan Scientific and Medical (Trajan) has completed the acquisition of the MyHealthTest blood testing service for an undisclosed sum. The acquisition further boosts Trajan’s ability to deliver analytical measurement services to society at a time when preventative healthcare strategies are becoming increasingly important.

Read More